350 related articles for article (PubMed ID: 32473620)
21. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.
Takata K; Kitamura Y
J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659
[TBL] [Abstract][Full Text] [Related]
22. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
Wang WY; Tan MS; Yu JT; Tan L
Ann Transl Med; 2015 Jun; 3(10):136. PubMed ID: 26207229
[TBL] [Abstract][Full Text] [Related]
23. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
24. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Laurent C; Buée L; Blum D
Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
[TBL] [Abstract][Full Text] [Related]
25. Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease.
Chen H; Deng C; Meng Z; Meng S
Front Biosci (Landmark Ed); 2022 Nov; 27(11):312. PubMed ID: 36472107
[TBL] [Abstract][Full Text] [Related]
26. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
[TBL] [Abstract][Full Text] [Related]
27. Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention.
Zhang G; Wang Z; Hu H; Zhao M; Sun L
Front Cell Neurosci; 2021; 15():749587. PubMed ID: 34899188
[TBL] [Abstract][Full Text] [Related]
28. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
Bowirrat A
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
[TBL] [Abstract][Full Text] [Related]
29. History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer's disease.
Sajad M; Kumar R; Thakur SC
IBRO Neurosci Rep; 2022 Jun; 12():377-389. PubMed ID: 35586776
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies.
Jha NK; Sharma A; Jha SK; Ojha S; Chellappan DK; Gupta G; Kesari KK; Bhardwaj S; Shukla SD; Tambuwala MM; Ruokolainen J; Dua K; Singh SK
Open Biol; 2020 Dec; 10(12):200286. PubMed ID: 33352062
[TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
32. The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer's disease.
Giorgi FS; Saccaro LF; Galgani A; Busceti CL; Biagioni F; Frati A; Fornai F
Brain Res Bull; 2019 Nov; 153():47-58. PubMed ID: 31419539
[TBL] [Abstract][Full Text] [Related]
33. Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology.
Hartman RE; Ross DM
Front Biosci (Elite Ed); 2018 Jan; 10(2):300-333. PubMed ID: 28930620
[TBL] [Abstract][Full Text] [Related]
34. Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease.
Shal B; Ding W; Ali H; Kim YS; Khan S
Front Pharmacol; 2018; 9():548. PubMed ID: 29896105
[TBL] [Abstract][Full Text] [Related]
35. Neuroinflammation in Alzheimer's disease.
Zhang F; Jiang L
Neuropsychiatr Dis Treat; 2015; 11():243-56. PubMed ID: 25673992
[TBL] [Abstract][Full Text] [Related]
36. Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease.
Rajesh Y; Kanneganti TD
Cells; 2022 Jun; 11(12):. PubMed ID: 35741014
[TBL] [Abstract][Full Text] [Related]
37. Neuroinflammation in Alzheimer's disease: protector or promoter?
Zilka N; Ferencik M; Hulin I
Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990
[TBL] [Abstract][Full Text] [Related]
38. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
39. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
40. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
